IJSTR

International Journal of Scientific & Technology Research

Home Contact Us
ARCHIVES
ISSN 2277-8616











 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

IJSTR >> Volume 2- Issue 3, March 2013 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



Platelet Rich Plasma, Is It Of Use In Human Intrabony Periodontal Defects

[Full Text]

 

AUTHOR(S)

Dr.Syed Wali Peeran, Dr. Fatma Mojtaba Alsaid

 

KEYWORDS

Key words: - Intrabony defects, Periodontology Platelet rich plasma, tissue engineering.

 

ABSTRACT

ABSTRACT: - Platelet-rich plasma is an autologous concentration of platelets. Scientific data has shown that this tissue-engineering tool, platelet rich plasma can enhance wound healing. Its use in periodontal surgeries is relatively recent. This paper tries to sketch a complete picture describing the use of platelet-rich plasma in human periodontal intrabony defects.

 

REFERENCES

[1]. R.E.Marx. Platelet-Rich Plasma (PRP): What is PRP and WHAT is not PRP? Implant Dentistry. 10(4).2001.

[2]. RE.Marx, ER.Carlson, RM.Eichstaedt, SR.Schimmele, JE.Strauss and KR.Georgeff. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.; 85(6):638-46.1998.

[3]. K.Okuda, T.Kawase, M.Momose, M.Murata, Y.Saito, H.Suzuki, LF.Wolff and H.Yoshie. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol ; 74(6):849-57.2003.

[4]. EA.Pepelassi, CE.Markopoulou, XE.Dereka, AA.Mamalis, IA.Vrotsos and M.Koutsilieris. Platelet-rich plasma effect on periodontally affected human gingival fibroblasts: an in vitro study. J Int Acad Periodontol.; 11(1):160-8.2009

[5]. H.El-Sharkawy, A.Kantarci, J.Deady, H.Hasturk, H.Liu, M.Alshahat and TE.Van Dyke. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol; 78(4):661-9.2007.

[6]. MQ.Kurikchy, NH.Al-Rawi, RS.Ayoub and SS.Mohammed. Histological evaluation of bone healing using organic bovine bone in combination with platelet-rich plasma (an experimental study on rabbits). Clin Oral Investig.10.1007/s00784-012-0751-z.2012.

[7]. V Lekovic, PM.Camargo, M.Weinlaender, N.Vasilic and EB.Kenney. Comparison of Platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J Periodontol. 73(2):198-205: 2002.

[8]. PM.Camargo, V.Lekovic, M.Weinlaender, N.Vasilic, M.Madzarevic and EB.Kenney. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res.37 (4):300-6:2002.

[9]. R.Hanna, PM.Trejo and RL.Weltman. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: a randomized clinical trial. J Periodontol 75(12):1668-77.2004.

[10]. K.Okuda, H.Tai, K.Tanabe, H.Suzuki, T.Sato, T.Kawase, Y.Saito, LF.Wolff and H.Yoshiex. Platelet-rich plasma combined a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: a comparative controlled clinical study. J Periodontol: 76(6):1287-1292.2005.

[11]. XY.Ouyang and J.Qiao. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans. Chin Med J (Engl). 20; 119 (18):1511-21.

[12]. J.Czuryszkiewicz-Cyrana and J.Banach. Autologous bone and platelet rich plasma (PRP) in the treatment of intrabony defects. Adv Med Sci ;51(1):26-30.2006

[13]. T.Ilgenli, N.Dündar and B.I.Kal. Demineralized freeze-dried bone allograft and platelet-rich plasma vs platelet-rich plasma alone in infrabony defects: a clinical and radiographic evaluation. Clin Oral Investig. 11(1):51-9.2007.

[14]. R.Papli and S.Chen. Surgical treatment of intrbony defects with autologous platelet concentrate or bioabsorbable barrier membrane: a prospective case series. J Periodontol: 78(1):185-93.2007.

[15]. F.Döri, T.Huszár, D.Nikolidakis, NB.Arweiler, I.Gera and A.Sculean. Effect of platelet-rich plasma on the healing of intra-bony defects treated with a natural bone mineral and a collagen membrane. J Clin Periodontol; 34(3):254-61.2007.

[16]. ZY.Berkman, O.Turner, T.Sbasioglu and A.Kantarci. Combined use of platelet-rich plasma and bone grafting with or without guided tissue regeneration in the treatment of anterior interproximal defects. J Periodontol ; 78(5):801-9.2007.

[17]. F.Döri, T.Huszar, D.Nikolidakis, NB.Arweiler, I.Gera and A.Sculean. Effect of platelet rich plasma on the healing of intrabony defects with an anorganic bovine bone mineral and expanded polytetrafluroethylene membranes. J Periodontol.78(6):938-90.2007.

[18]. B.Demir, D.Sengün and A.Berberoğlu. Clinical evaluation of platelet-rich plasma and bioactive glass in the treatment of intra-bony defects. J Clin Periodontol; 34(8):709-15. 2007.

[19]. S.Yilmaz, G.Cakar, B.E.Kuru and B.Yildirim. Platelet-rich plasma in combination with bovine derived xenograft in the treatment of generalized aggressive periodontitis: a case report with re-entry. Platelets; 18(7):535-9.2007.

[20]. F.Döri, D.Nikolidakis, T.Húszár, N.B.Arweiler, I.Gera and A.Sculean. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral. J Clin Periodontol ; 35(1):44-50.2008.

[21]. F.Döri, T.Húszár, D.Nikolidakis, D.Tihanyi, A.Horváth, NB.Arweiler, I.Gera and A.Sculean. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes. J Periodontol ; 79(4):660-9.2008.

[22]. M.Piemontese, S.D.Aspriello, C.Rubini, L.Ferrante and M.Procaccini. Treatment of periodontal intrabony defects with demineralized freeze-dried bone allograft in combination with platelet-rich plasma: a comparative clinical trail. J Periodontol. 79(5):802-10:2008.

[23]. K.Yamamiya, K.Okuda, T.Kawase, K.Hata ,L.F.Wolf and H.Yoshie. Tissue-engineered cultured periosteum used with platelet-rich plasma and hydroxyapatite in treating human osseous defects. J Periodontol.79 (5):811-8.2008.

[24]. L.Harnack, R.H.Boedeker, I.Kurtulus, S.Boehm, J.Gonzales and J.Meyle. Use of platelet-rich plasma in periodontal surgery-a prospective randomized double blind clinical trail. Clin Oral Investig; 13(2):179-87.2009.

[25]. A.R.Pradeep, SK.Shetty, G.Garg and S.Pai. Clinical effectiveness of autologous platelet-rich plasma and Peptide-enhanced bone graft in the treatment of intrabony defects. J Periodontol. 80(1):62-71.2009.

[26]. PM.Camargo, V.Lekovic, M.Weinlaender, T.Divnic-Resnik, M.Pavlovic and EB.Kenney. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontol. 80(6):915-23. 2009.

[27]. F.Döri, V.Kovás, NB.Arweiler, T.Huszár, I.Gera, D.Nikolidakis and A.Sculean. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study. J Periodontol .80(10):1599-605 .2009.

[28]. S.Yilmaz, G.Cakar, B.Kuru, S.Dirikan and B.Yildirim. Platelet-rich plasma in combination with bovine derived xenograft in the treatment of deep intrabony periodontal defects: a report of 20 consecutively treated patients. Platelets; 20(6):432-40.2009.

[29]. G.Sammartino, M.Tia, E.Gentile, G.Marenzi and PP.Claudio. Platelet-rich plasma and resorbable membrane for prevention of periodontal defects after deeply impacted lower third molar extraction. J Oral Maxillofacial Surg; 67(11):2369-73.2009.

[30]. N.Markou, E.Pepelassi, H.Vavouraki, HC.Stamatakis, G.Nikolopoulos, I.Vrotsos and K.Tsiklakis. Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: a comparative clinical trial. J Periodontol. 80(12):1911-9.2009.

[31]. M.Parimala and DS.Mehta. Comparative evaluation of bovine porous bone mineral. J Indian Soc Periodontol; 14(2):126-31.2010.

[32]. N.Markou, E.Pepelassi, S.Kotsovilis, I.Vrotsos, H.Vavouraki and HC.Stamatakis. The use of platelet-rich plasma combined with demineralized freeze-dried bone allograft in the treatment of periodontal endosseous defects: a report of two clinical cases. J Am Dent Assoc. 141(8):967-78.2010.

[33]. S.Yilmaz, C.Kabadayi, SD.Ipci, G.Cakar, B.Kuru. Treatment of intrabony periodontal defects with platelet-rich plasma versus platelet-poor plasma combined with a bovine-derived xenograft: a controlled clinical trial. J Periodontol; 82(6):837-44. 2011.
[34]. SV.Rodrigues, AB.Acharya and SL.Thakur. An evaluation of platelet-rich plasma without thrombin activation with or without anorganic bone mineral in the treatment of human periodontal intrabony defects. Platelets 22(5):353-60.2011.

[35]. N.Saini, P.Sikri and H.Gupta. Evaluation of the relative efficacy of autologous platelet-rich plasma in combination with β-tricalcium phosphate alloplast versus an alloplast alone in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J Dent Res; 22(1):107-15.2011.

[36]. BT.Kaushick, ND.Jayakumar, O.Padmalatha and S.Varghese. Treatment of human periodontal intrabony with hydroxyapatite+β tricalcium phosphate bone graft alone and in combination with platelet rich plasma: a randomized clinical trial. Indian J Dent Res; 22(4):505-10.2011.

[37]. B.Ozdemir and E.Okte. Treatment of intrabony defects with beta-tricalcium phosphate alone and in combination with platelet-rich plasma. J Biomed Mater Res B Appl Biomater. 100(4):976-83 .2012.

[38]. AR.Pradeep, NS.Rao, E.Agarwal, P.Bajaj, M.Kumari and SB.Naik. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial. J.Periodontol. 83(12):1499-507.2012.

[39]. KS.Hassan, AS.Alagl and A.Abdel-Hady. Torus mandibularis bone chips combined with platelet rich plasma gel for treatment of intrabony osseous defects: clinical and radiographic evaluation. Int J Oral Maxillofacial Surg.41 (12):1519-26. 2012.

[40]. LM. Menezes and J. Rao. Long-term clinical evaluation of platelet-rich plasma in the treatment of human periodontal intraosseous defects: A comparative clinical trial. Quintessence Int. 43(7):571-82.2012.